[1]
“Validation of a New Scoring System for Treatment Failure in CML Patients on Tyrosine Kinase Inhibitors in a real world setting ”, Mediterr J Hematol Infect Dis, vol. 18, no. 1, p. e2026013, Jan. 2026, doi: 10.4084/MJHID.2026.013.